,使,:

Njeri Wairimu1, Kenneth Ngure2, Vallery Ogello1

  • 1Partners in Health Research and Development, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.

PubMed
概括

许多人停止服用艾滋病毒暴露前预防药物 (PrEP),因为他们认为感染艾滋病毒的风险很低. 有效的咨询至关重要,以帮助人们准确评估他们的风险,并指导适当的PrEP停用.